StockData
USANA Health Sciences Inc logo

USANA Health Sciences Inc (USNA) stock

USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.22−0.35 (-2.58%)

Close on Nov 18, 2026Market cap $244.26MP/E –Yield –

USANA Health Sciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

USANA Health Sciences's operating income for the twelve months ending Jul 4, 2026 was -$1.08M, down 101.9% year over year. For fiscal 2025 it was $37.43M, down 43.6% from the year before. Over ten years it grew -12.5% a year on average. The highest annual figure on record is $188.35M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Jan 3, 2026$37.43M-43.6%
FY2024Dec 28, 2024$66.32M-28.7%
FY2023Dec 30, 2023$93.07M-13.5%
FY2022Dec 31, 2022$107.61M-36.8%
FY2021Jan 1, 2022$170.19M-3.6%
FY2020Jan 2, 2021$176.49M+20.7%
FY2019Dec 28, 2019$146.19M-22.4%
FY2018Dec 29, 2018$188.35M+42.1%
FY2017Dec 30, 2017$132.50M-4.4%
FY2016Dec 31, 2016$138.62M-2.1%
FY2015Jan 2, 2016$141.66M+22.0%
FY2014Jan 3, 2015$116.10M-0.5%
FY2013Dec 28, 2013$116.71M+18.9%
FY2012Dec 29, 2012$98.18M+27.1%
FY2011Dec 31, 2011$77.26M+13.3%
FY2010Jan 1, 2011$68.22M+34.3%
FY2009Jan 2, 2010$50.79M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jul 4, 2026-$20.00M-219.6%
Q1 FY2026Apr 4, 2026$13.87M-11.5%
Q4 FY2025Jan 3, 2026$3.82M-53.5%
Q3 FY2025Sep 27, 2025$1.22M-92.2%
Q2 FY2025Jun 28, 2025$16.72M-6.3%
Q1 FY2025Mar 29, 2025$15.67M-36.5%
Q4 FY2024Dec 28, 2024$8.21M-66.1%
Q3 FY2024Sep 28, 2024$15.60M-11.4%
Q2 FY2024Jun 29, 2024$17.84M-26.9%
Q1 FY2024Mar 30, 2024$24.67M-8.1%
Q4 FY2023Dec 30, 2023$24.22M+7.4%
Q3 FY2023Sep 30, 2023$17.61M-22.2%
Q2 FY2023Jul 1, 2023$24.40M-16.9%
Q1 FY2023Apr 1, 2023$26.85M-18.8%
Q4 FY2022Dec 31, 2022$22.55M-28.4%
Q3 FY2022Oct 1, 2022$22.63M-44.5%
Q2 FY2022Jul 2, 2022$29.37M-45.3%
Q1 FY2022Apr 2, 2022$33.07M-25.2%
Q4 FY2021Jan 1, 2022$31.51M-40.0%
Q3 FY2021Oct 2, 2021$40.77M-10.1%
Q2 FY2021Jul 3, 2021$53.72M+35.7%
Q1 FY2021Apr 3, 2021$44.20M+13.3%
Q4 FY2020Jan 2, 2021$52.54M+17.9%
Q3 FY2020Sep 26, 2020$45.36M+27.9%
Q2 FY2020Jun 27, 2020$39.59M+27.1%
Q1 FY2020Mar 28, 2020$39.01M+11.5%
Q4 FY2019Dec 28, 2019$44.57M-8.2%
Q3 FY2019Sep 28, 2019$35.46M-22.1%
Q2 FY2019Jun 29, 2019$31.16M-39.1%
Q1 FY2019Mar 30, 2019$35.00M-18.8%
Q4 FY2018Dec 29, 2018$48.57M+35.3%
Q3 FY2018Sep 29, 2018$45.51M+45.1%
Q2 FY2018Jun 30, 2018$51.14M+58.0%
Q1 FY2018Mar 31, 2018$43.13M+31.1%
Q4 FY2017Dec 30, 2017$35.89M+12.7%
Q3 FY2017Sep 30, 2017$31.36M-12.5%
Q2 FY2017Jul 1, 2017$32.37M–
Q1 FY2017Apr 1, 2017$32.89M–
Q4 FY2016Dec 31, 2016$31.84M–
Q3 FY2016Oct 1, 2016$35.83M–

More USANA Health Sciences figures

See a number that looks wrong?